ACC CardiaCast

In this episode, Scott Solomon, Ankeet Bhatt, and Orly Vardeny are joined by William Schaffner to discuss the importance of influenza vaccination particularly this year in the midst of the coronavirus disease 2019 pandemic.

In this episode, Scott Solomon, Ankeet Bhatt, Orly Vardeny, Mohammad Madjid, and Jay Udell take a step back to dive deeper into the mechanisms behind the association between influenza and acute cardiovascular events. Visit the Taking the Lead: Flu and Cardiovascular Disease hub for more information and resources.

In this episode, Scott Solomon, Ankeet Bhatt, and Orly Vardeny discuss the intersection of influenza and cardiology and why cardiovascular practitioners should be concerned about influenza, particularly in the era of coronavirus disease 2019. Visit the Taking the Lead: Flu and Cardiovascular Disease hub for more information and resources.

In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the main features from the recently published 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and how to apply the key points from this document in your practice.

Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.

In this episode, Christopher Granger is joined by Melissa Magwire, a registered nurse and Practice Manager at Saint Luke's Cardiometabolic Center Alliance, to discuss advances in how to optimally treat patients with diabetes and cardiovascular disease and how to spread the model for organizing this care across the United States.

In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the role of GLP-1 receptor agonists and SGLT2 inhibitors in cardiology, what cardiologists need to know to use these drugs safely and effectively, and how important it is to understand their role in the use of these drugs

In this episode, Christopher Granger and Robert Eckel discuss how to improve the care of patients with type 2 diabetes and cardiovascular disease, including using antihyperglycemic drugs that have relatively recently been shown to have an important effect on reducing cardiovascular outcomes. Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.

In this episode, Michelle Kittleson discusses five high-yield tips for the diagnosis and management of hypertrophic cardiomyopathy.

Hear about tomorrow's emerging sources of real-world data and how the role of the clinician at the bedside contributes to this burgeoning field. Dr. Ty Gluckman, Dr. Nihar Desai, and Dr. Rashmee Shah discuss how researchers and clinicians can shape their career trajectories to take part in this data revolution, both utilizing and contributing to real-world evidence that supports quality metrics, institutional improvements, and better patient care.

As patient populations increase in complexity, the use of real-world evidence (RWE) to identify sub-populations that need non-traditional approaches to solving clinical problems is likely to increase as well. Dr. Ty Gluckman and Dr. Nihar Desai explain how RWE can bridge the gaps in randomized controlled trial evidence, supporting clinical decision-making with evidence that better reflects your real-world patient population.